Female Health Co (FHCO.OQ)
FHCO.OQ on NASDAQ Stock Exchange Capital Market
9.15USD
1 Aug 2013
9.15USD
1 Aug 2013
Price Change (% chg)
$-0.03 (-0.33%)
$-0.03 (-0.33%)
Prev Close
$9.18
$9.18
Open
$9.15
$9.15
Day's High
$9.15
$9.15
Day's Low
$9.15
$9.15
Volume
2,700
2,700
Avg. Vol
--
--
52-wk High
--
--
52-wk Low
--
--
About
The Female Health Company (FHC) manufactures, markets and sells the FC2 female condom. FC2 is approved by the United States Food and Drug Administration (FDA) that provides dual protection against unintended pregnancy and sexually transmitted infections (STIs), including Human immunodeficiency virus/acquired immunodeficiency... (more)
Overall
| Beta: | 0.75 |
| Market Cap (Mil.): | $262.93 |
| Shares Outstanding (Mil.): | 28.64 |
| Dividend: | 0.07 |
| Yield (%): | 3.05 |
Financials
| FHCO.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 14.86 | 54.61 | 39.77 |
| EPS (TTM): | 0.62 | -- | -- |
| ROI: | 80.80 | 6.88 | 66.51 |
| ROE: | 82.17 | 8.74 | 72.84 |
Competitors
| Price | Change | |
|---|---|---|
| The Procter & Gamble Company (PG.N) | $81.96 | +1.66 |
| SAGAMI RUBBER INDUSTRIES CO., LTD. (5194.T) | ¥270 | +10.00 |
| Cupid Ltd (CUCO.BO) | Rs10.65 | -0.50 |
| Polar Pharma India Ltd (POLP.BO) | Rs0.97 | +0.04 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

